Novartis Ag (NVS) Revenue (2009 - 2026)
Novartis Ag's Revenue came in at $14.41 billion for Q2 2026, up 2.5% from $14.05 billion a year earlier and up 9.9% from the prior quarter.
Novartis Ag (NVS) Revenue (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Revenue of $54.77 billion, up 2.8% year-over-year; for FY2025, it came in at $54.53 billion, up 8.4% from FY2024.
- Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- Going back by year, Revenue was $50.32 billion in FY2024 (+10.7%), $45.44 billion in FY2023 (+7.7%), $42.21 billion in FY2022 (-1.3%) and $42.78 billion in FY2021 (-12.1%).
- The Q2 2026 figure represents the highest quarterly Revenue since Q4 2012.
- Year-over-year, Revenue increased in seven of the last eight quarters, with growth averaging 7.5%.
- The fastest year-over-year change in Revenue over five years came in Q4 2024 (growth of 15.1%), and the weakest in Q4 2022 (a decline of 20.1%).
- Business Quant data shows NVS's Revenue at $13.11 billion (Q1 2026), $13.34 billion (Q4 2025) and $13.91 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 212,806.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 24.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 25.40 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 17.40 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 18.09 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 16.58 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.41 Bn |
| Mar 31, 2026 | 13.11 Bn |
| Dec 31, 2025 | 13.34 Bn |
| Sep 30, 2025 | 13.91 Bn |
| Jun 30, 2025 | 14.05 Bn |
| Mar 31, 2025 | 13.23 Bn |
| Dec 31, 2024 | 13.15 Bn |
| Sep 30, 2024 | 12.82 Bn |
| Jun 30, 2024 | 12.51 Bn |
| Mar 31, 2024 | 11.83 Bn |
| Dec 31, 2023 | 11.42 Bn |
| Sep 30, 2023 | 11.78 Bn |
| Jun 30, 2023 | 11.44 Bn |
| Mar 31, 2023 | 10.80 Bn |
| Dec 31, 2022 | 10.58 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 12.78 Bn |
| Mar 31, 2022 | 12.53 Bn |
| Dec 31, 2021 | 13.23 Bn |
| Sep 30, 2021 | 13.03 Bn |
Novartis Ag Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();